$115 Million is the total value of Lynx1 Capital Management LP's 10 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRUS | New | MERUS N V | $24,912,000 | – | 783,398 | +100.0% | 21.74% | – |
| TVTX | New | TRAVERE THERAPEUTICS INC | $22,878,000 | – | 737,061 | +100.0% | 19.96% | – |
| ALPN | New | ALPINE IMMUNE SCIENCES INC | $17,478,000 | – | 1,261,927 | +100.0% | 15.25% | – |
| BLU | New | BELLUS HEALTH INC NEW | $16,125,000 | – | 2,003,114 | +100.0% | 14.07% | – |
| IMGN | New | IMMUNOGEN INC | $15,801,000 | – | 2,129,531 | +100.0% | 13.79% | – |
| New | PARDES BIOSCIENCES INC | $6,574,000 | – | 401,593 | +100.0% | 5.74% | – | |
| New | THESEUS PHARMACEUTICALS INC | $5,191,000 | – | 409,358 | +100.0% | 4.53% | – | |
| CBAY | New | CYMABAY THERAPEUTICS INC | $4,140,000 | – | 1,224,968 | +100.0% | 3.61% | – |
| PIRS | New | PIERIS PHARMACEUTICALS INC | $1,449,000 | – | 383,266 | +100.0% | 1.26% | – |
| OTIC | New | OTONOMY INC | $62,000 | – | 30,000 | +100.0% | 0.05% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MERUS N V | 8 | Q3 2023 | 21.9% |
| ALPINE IMMUNE SCIENCES INC | 8 | Q3 2023 | 20.2% |
| CYMABAY THERAPEUTICS INC | 8 | Q3 2023 | 10.0% |
| THESEUS PHARMACEUTICALS INC | 8 | Q3 2023 | 5.6% |
| PIERIS PHARMACEUTICALS INC | 8 | Q3 2023 | 5.8% |
| KINNATE BIOPHARMA INC | 7 | Q3 2023 | 18.0% |
| PARDES BIOSCIENCES INC | 7 | Q2 2023 | 11.0% |
| PASSAGE BIO INC | 7 | Q3 2023 | 4.0% |
| BELLUS HEALTH INC NEW | 6 | Q1 2023 | 22.7% |
| CABALETTA BIO INC | 4 | Q3 2023 | 22.6% |
View Lynx1 Capital Management LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-23 |
| SC 13G | 2024-04-01 |
| SC 13G | 2024-03-29 |
| SC 13G | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Lynx1 Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.